Herantis Pharma Oyj (HEL:HRTIS)

Herantis Pharma Oyj Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	0.64	5.5	5.04	6.44	12.34
Short-Term Investments	1.5	0.99	0.96	0.99	0.99
Cash & Short-Term Investments	2.14	6.49	5.99	7.42	13.32
Cash Growth	-67.09%	8.30%	-19.31%	-44.28%	90.41%
Other Receivables	0.41	0.24	0.2	0.12	0.17
Receivables	0.41	0.24	0.2	0.12	0.17
Prepaid Expenses	0.03	0.02	0.04	0.06	0.04
Other Current Assets	-0	-	-	-	-
Total Current Assets	2.57	6.75	6.23	7.6	13.54
Long-Term Deferred Charges	-	-	-	0.16	2.88
Total Assets	2.57	6.75	6.23	7.76	16.42
Accounts Payable	0.28	0.75	0.66	0.79	0.72
Accrued Expenses	0.32	1.13	1.06	0.73	0.82
Current Portion of Long-Term Debt	0.01	0	0.15	0.91	1.27
Current Portion of Leases	-	0.04	-	0.13	-
Other Current Liabilities	0.03	0.06	0.03	0.05	0.09
Total Current Liabilities	0.63	1.99	1.9	2.61	2.89
Long-Term Debt	0.03	0.03	4.39	6.29	5.94
Other Long-Term Liabilities	2.16	-	-	0	-
Total Liabilities	2.81	2.02	6.29	8.9	8.83
Common Stock	0.08	0.08	0.08	0.08	0.08
Retained Earnings	-80.07	-75.1	-75.38	-67.75	-54.98
Comprehensive Income & Other	79.75	79.75	75.24	66.53	62.49
Shareholders' Equity	-0.24	4.73	-0.06	-1.14	7.59
Total Liabilities & Equity	2.57	6.75	6.23	7.76	16.42
Total Debt	0.03	0.08	4.54	7.33	7.21
Net Cash (Debt)	2.11	6.41	1.45	0.09	6.12
Net Cash Growth	-67.16%	342.20%	1482.98%	-98.50%	-
Net Cash Per Share	0.10	0.37	0.10	0.01	0.83
Filing Date Shares Outstanding	20.16	20.16	16.91	11.1	9.76
Total Common Shares Outstanding	20.16	20.16	16.91	11.1	9.76
Working Capital	1.94	4.76	4.33	4.99	10.65
Book Value Per Share	-0.01	0.23	-0.00	-0.10	0.78
Tangible Book Value	-0.24	4.73	-0.06	-1.14	7.59
Tangible Book Value Per Share	-0.01	0.23	-0.00	-0.10	0.78

Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.